Allianz Asset Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-75,375
| Closed | -$2.97M | – | 2299 |
|
|
2023
Q2 | $2.97M | Buy |
75,375
+25,275
| +50% | +$892K | 0.01% | 1110 |
|
|
2023
Q1 | $1.22M | Sell |
50,100
-12,000
| -19% | -$263K | ﹤0.01% | 1608 |
|
|
2022
Q4 | $1.33M | Buy |
62,100
+13,900
| +29% | +$297K | ﹤0.01% | 1421 |
|
|
2022
Q3 | $865K | Sell |
48,200
-248,349
| -84% | -$3.26M | ﹤0.01% | 1438 |
|
|
2022
Q2 | $2.85M | Sell |
296,549
-79,684
| -21% | -$1M | ﹤0.01% | 1291 |
|
|
2022
Q1 | $6.33M | Buy |
376,233
+194,432
| +107% | +$2.87M | ﹤0.01% | 1143 |
|
|
2021
Q4 | $3.03M | Buy |
181,801
+86,751
| +91% | +$1.42M | ﹤0.01% | 1443 |
|
|
2021
Q3 | $1.54M | Buy |
+95,050
| New | +$1.03M | ﹤0.01% | 1749 |
|
|
2016
Q4 | – | Sell |
-261,434
| Closed | -$13.9M | – | 2697 |
|
|
2016
Q3 | $13.9M | Sell |
261,434
-94,833
| -27% | -$5.35M | 0.01% | 1161 |
|
|
2016
Q2 | $18.2M | Buy |
356,267
+80,960
| +29% | +$4.02M | 0.02% | 956 |
|
|
2016
Q1 | $11.6M | Buy |
275,307
+7,037
| +3% | +$359K | 0.01% | 1056 |
|
|
2015
Q4 | $21M | Buy |
268,270
+24,800
| +10% | +$1.43M | 0.02% | 729 |
|
|
2015
Q3 | $9.87M | Buy |
243,470
+30,770
| +14% | +$1.63M | 0.01% | 999 |
|
|
2015
Q2 | $11.1M | Sell |
212,700
-122,160
| -36% | -$6.08M | 0.01% | 1053 |
|
|
2015
Q1 | $15.6M | Buy |
334,860
+4,700
| +1% | +$244K | 0.02% | 780 |
|
|
2014
Q4 | $14.8M | Buy |
330,160
+111,205
| +51% | +$4.67M | 0.02% | 818 |
|
|
2014
Q3 | $8.52M | Buy |
218,955
+12,240
| +6% | +$480K | 0.01% | 888 |
|
|
2014
Q2 | $8.75M | Buy |
+206,715
| New | +$7.58M | 0.01% | 770 |
|
Allianz Asset Management's ISEE Position: Q3 2023 in Review
Allianz Asset Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 75,375 shares — an estimated $2.97M sold.
Allianz Asset Management first reported a position in ISEE in Q2 2014 and held it in 18 quarters. The position peaked at $21M in Q4 2015. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- Allianz Asset Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- Allianz Asset Management sold 75,375 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $2.97M.
- Allianz Asset Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 18 quarters.
- Allianz Asset Management's IVERIC bio, Inc. Common Stock position peaked at $21M in Q4 2015.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on Allianz Asset Management's 13F filing for Q3 2023, filed 13 Nov 2023.